DFTX Q1 2020 Earnings — Definium Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DFTXDefinium Therapeutics, Inc.

$2B

Q1 2020 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$4M

Net Income

-$7M

EPS (Diluted)

$-0.52

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$26M

Total Liabilities

$2M

Stockholders' Equity

$24M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$1,669	+100.0%
Operating Income	-$4M	-$131,552	-3120.8%
Net Income	-$7M	-$167,150	-4107.6%